Lee Bill Cuts Drug Prices and Red Tape
WASHINGTON – U.S. Senator Mike Lee (R-UT) introduced the bipartisan Biosimilar Red Tape Elimination Act today to cut drug prices for consumers and increase competition in the pharmaceutical market by categorizing generic-brand “biosimilar” drugs as interchangeable with their name-brand counterparts. Senators Rand Paul (R-KY), Maggie Hassan (D-NH), and Ben Ray Luján (D-NM) cosponsored the legislation.